ADMA Biologics, Inc.ADMANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+49.0%
5Y CAGR+64.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+49.0%/yr
vs +73.5%/yr prior
5Y CAGR
+64.6%/yr
Recent deceleration
Acceleration
-24.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
12.1x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$510.17M+19.6%
2024$426.45M+65.2%
2023$258.21M+67.6%
2022$154.08M+90.4%
2021$80.94M+91.7%
2020$42.22M+43.9%
2019$29.35M+72.8%
2018$16.99M-25.4%
2017$22.76M+113.5%
2016$10.66M-